Roth Capital Initiates Coverage On Nuo Therapeutics with Buy Rating, Announces Price Target of $3
Nuo Therapeutics Announces Exclusive Private Label Distribution Agreement with Smith+Nephew
Nuo Therapeutics Enters Into Exclusive Private Label Distribution Agreement With Global Medical Technology Company For The CENTRIO Platelet-Rich Plasma System
Nuo Therapeutics and PAM Health Partner to Advance Access to Regenerative Wound Healing Therapies
Audeo Oncology Files to Withdraw S-1 for IPO
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.
